Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 3 of the 11 sources its claims cite were checked for support.
Abstract
The quantitative contributions of pancreatic responsiveness and insulin sensitivity to glucose tolerance were measured using the "minimal modeling technique" in 18 lean and obese subjects (88-206% ideal body wt). The individual contributions of insulin secretion and action were measured by interpreting the dynamics of plasma glucose and insulin during the intravenous glucose tolerance test in terms of two mathematical models. One, the insulin kinetics model, yields parameters of first-phase (phi 1) and second-phase (phi 2) responsivity of the beta-cells to glucose. The other glucose kinetics model yields the insulin sensitivity parameters, SI. Lean and obese subjects were subdivided into good (KG greater than 1.5) and lower (KG less than 1.5) glucose tolerance groups. The etiology of lower glucose tolerance was entirely different in lean and obese subjects. Lean, lower tolerance was related to pancreatic insufficiency (phi 2 77% lower than in good tolerance controls [P less than 0.03]), but insulin sensitivity was normal (P greater than 0.5). In contrast, obese lower tolerance was entirely due to insulin resistance (SI diminished 60% [P less than 0.01]); pancreatic responsiveness was not different from lean, good tolerance controls (phi 1: P greater than 0.06; phi 2: P greater than 0.40). Subjects (regardless of weight) could be segregated into good and lower tolerance by the product of second-phase beta-cell responsivity and insulin sensitivity (phi 2 . SI). Thus, these two factors were primarily responsible for overall determination of glucose tolerance. The effect of phi 1 was to modulate the KG value within those groups whose overall tolerance was determined by phi 2 . SI. This phi 1 modulating influence was more pronounced among insulin sensitive (phi 1 vs. KG, r = 0.79) than insulin resistant (obese, low tolerance; phi 1 vs. KG, r = 0.91) subjects. This study demonstrates the feasibility of the minimal model technique to determine the etiology of impaired glucose tolerance.
Overview
CoChat Summary
TL;DR
The paper applies the “minimal modeling” technique to intravenous glucose tolerance tests in 18 lean and obese subjects to quantify insulin sensitivity and β-cell glucose responsiveness. It finds that low glucose tolerance in lean subjects is due mainly to pancreatic insufficiency, whereas in obese subjects it is due mainly to insulin resistance.
Key findings
- Lean subjects with lower glucose tolerance had a 77% lower second-phase β-cell responsivity (φ2) than lean good-tolerance controls (P < 0.03), while insulin sensitivity was normal (P > 0.5).
- Obese subjects with lower glucose tolerance had insulin sensitivity diminished by 60% versus lean good-tolerance controls (P < 0.01), with pancreatic responsiveness not significantly different (φ1: P > 0.06; φ2: P > 0.40).
- The product φ2·S segregated tolerance: good-tolerance subjects averaged 160 ± 26 versus 40 ± 7 for low-tolerance subjects (P < 0.001); a φ2·S threshold of 75 separated 9 of 10 low-tolerance and 7 of 8 good-tolerance subjects.
- First-phase responsivity (φ1) modulated KG within groups: φ1 vs KG correlated r = 0.79 in insulin-sensitive subjects and r = 0.91 in insulin-resistant obese low-tolerance subjects; glucose effectiveness (P1) was lower in low-tolerance subjects (1.4 ± 0.2 vs. 3.6 ± 0.3 %/min, P < 0.01).
Methods
- IVGTT was performed in 18 subjects (8 male, 10 female; 88–206% ideal body weight) after an overnight fast, with 300 mg/kg glucose injected over 60 s and frequent plasma glucose and insulin sampling.
- Two minimal mathematical models were used: a glucose kinetics model to estimate insulin sensitivity (S) and an insulin kinetics model to estimate first-phase (φ1) and second-phase (φ2) β-cell responsivity to glucose.
- Parameters were estimated by nonlinear least squares with covariance-matrix accuracy assessment; subjects were divided into good tolerance (KG > 1.5) and lower tolerance (KG < 1.5), and comparisons used Student’s t test and regression.
Limitations
- The paper states that complete validation of the model and optimal input patterns is required before the approach can be proposed as a clinical tool, and that more study of the range of glucose doses over which the model applies would be worthwhile.
- The authors note that the present studies were limited to testing whether the model and its parameters apply and can be obtained from other doses and stimulus patterns.
- Evident from the text: the sample is small (n = 18), the tolerance cutoff at KG = 1.5 was arbitrary because no KG values fell between 1.4 and 1.8, and φ1 varied widely within groups, limiting clear segregation by φ1·S.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




![FiGURE 4 Ability of the minimal models to describe glucose and insulin kinetics during the IVGTT (examples). Insulin and glucose data are represented by open (O) and filled () circles. Prediction of the insulin kinetics model are the solid curves; upper panels. Glucose kinetics model predicts the time-course of plasma glucose (solid curves, lower panels) as well as the timecourse of "insulin action" (dashed line upper panels; remote insulin [X] in the model of Fig. la).](https://figures.cochat.ai/paper-figures/f6e06f75ebdc4bef964605372991c28c/physiologic-evaluation-of-factors-controlling-glucose-tolerance-in-man-figure-4.png)



Verification
Claims the paper makes
2 Valid · 0 Not valid · 4 Not checked · 44 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“During the past decade, several laboratories have approached this problem by breaking the feedback relationship, either by pharmacological suppression of pancreatic insulin secretion (10) or by external feedback control (glucose clamp) to circumvent the effect of plasma insulin to change plasma glucose (11).”
What the sources say
- Supportedcites [10] 10. Shen, S-W., G. M. Reaven, and J. W. Farquhar. 1970. Comparison of impedance to insulin-mediated glucose uptake in normal and diabetic subjects.J. Clin. Invest. 49: 2151-2160. source
The Introduction (p. 1, 'Dr. Shen is a Postdoctoral Research Fellow' section) states the approach the citing sentence attributes to this reference: subjects received a constant intravenous infusion of exogenous crystalline insulin while 'endogenous insulin secretion was inhibited by the simultaneous administration of low doses of epinephrine and propranolol,' so that the steady-state plasma glucose during a constant glucose infusion measures impedance to insulin-mediated glucose uptake, and such measurements 'should eliminate some of the variables of an intact feedback loop.' The Discussion ('§ Values obtained from') confirms the pharmacological blockade worked (immunoreactive insulin fell to <50% of fasting and remained low despite plasma glucose of 316 and 398 mg/100 ml), and that its primary goal was to consider only a constant level of exogenous insulin. Our copy does not describe external feedback control (glucose clamp), but that half of the sentence is carried by the separate citation (11), not by this source; likewise 'during the past decade, several laboratories' is the citing authors' framing. Note the propranolol-epinephrine inhibition method is credited to Porte (ref 36), but Shen et al. report and rely on it as their own experimental approach, so the identification citation stands. (LLM, conf=0.88)
- Supportedcites [11] 11. Insel, P. A., J. E. Liljenquist, J. D. Tobin, R. S. Sherwin, P. Watkins, R. Andres, and M. Berman. 1975. Insulin control of glucose metabolism in man. J. Clin. Invest. 55: 1057-1066. source
The citation is attached to the glucose-clamp branch of the sentence (the pharmacological-suppression branch carries a different reference), and our copy is exactly that kind of work: the Introduction (p. 1057) states that 'the maintenance of blood sugar in man is a complex process involving feedback control of insulin on glucose and of glucose on insulin' and that 'by use of the glucose clamp technique (1, 2), the blood glucose concentration is maintained by a feedback-controlled glucose infusion.' The Abstract (p. 1057) confirms the purpose — insulin-induced changes in blood glucose activate counterregulatory mechanisms, 'to eliminate such mechanisms, we have employed the glucose clamp technique which allows maintenance of fasting blood glucose concentration,' and the Discussion (p. 1063) presents the clamp (with kinetic modeling) as an approach to estimating tissue sensitivity to insulin, contrasting it with the insulin tolerance test and 'glucose impedance.' The 'several laboratories' framing is the citing authors' own summary, not a point attributed to this source. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Thus, our results are consistent with the diminished S of obese subjects elucidated by both qualitative (26) and quantitative techniques (25).”
What the sources say
- Not checked — no full text of the sourcecites [26] 26. Kolterman, O., G. M. Reaven, and J. M. Olefsky. 1979. Relationship between in vivo insulin resistance and decreased insulin receptors in obese men. J. Clin. Endocrinol. Metab. 48: 487-494. source
- Supportedcites [25] 25. DeFronzo, R., V. Soman, R. Sherwin, R. Hendler, and P. Felig. 1979. Insulin binding to monocytes and insulin action in human obesity, starvation and refeeding. J. Clin. Invest. 63: 204–213. source
The citation is attached to “quantitative techniques.” The Discussion reports that insulin sensitivity was quantified with the euglycemic insulin clamp and was 52% lower in postabsorptive obese subjects. This supports the attributed finding of diminished insulin sensitivity (S); the qualitative-techniques citation is separate. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the obese glucose space exceeded the space of lean individuals by only 16% (Table II).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“an increase of φ1 from 1 to 10 was associated with an increase in KG of only 0.3 min−¹.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because the diminished glucose effectiveness of obese subjects is independent of acute changes in insulin”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
27 more claims
Create a free account to see all 50 claims and every source verdict.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 14
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As postulated previously [93], we found that the relationship between insulin sensitivity and insulin secretion is non-linear and best described by a hyperbolic function.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [93]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies have demonstrated that to maintain glucose homeostasis, a feedback loop exists in which decreased insulin sensitivity is tightly associated with increased insulin secretion from the beta cell, with this hyperbolic relationship between beta cell responsivity and insulin sensitivity termed the disposition index67,68.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [68]
Experimental — accuracy not yet measuredIn the citing paper
“the product of insulin sensitivity and the acute insulin response to intravenous glucose, called the disposition index [93], declined in the group as a whole and was associated with a mild deterioration of intravenous glucose tolerance.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 6 | 1.06 | 8.9 | 5.1 | 1.4 | 4.5 |”
Reported 4.5 · recomputed 45.39
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ RESULTS · p. 7
“In the glucose kinetics model (Fig. 1b) the coefficient P1 is the insulin-independent fractional turnover constant for glucose disposition”
§ B MINIMAL MODEL OF INSULIN KINETICS · p. 3
“(B) Model of insulin kinetics used to calculate pancreatic responsivity parameters φ1 and φ2 (12).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ METHODS · p. 2
“glucose (300 mg/kg) was injected smoothly over 60 s, starting at time (t) = 0.”
§ RESULTS · p. 6
“Glucose (330 mg/kg) was injected over 1 min starting at t = 0.”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1172/jci109108 · retraction date not known · this paper published 1981-12-01
Citations
Cites
1 retracted
Insulin Binding to Monocytes and Insulin Action in Human Obesity, Starvation, and Refeeding
Defronzo, R. A., Soman, V., Sherwin, R. S., Hendler, R., & Felig, P. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109108 · Cited by 252
RetractedQuantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 4×
“We have referred to the sum of these factors as "glucose effectiveness" (13).”
InfluentialSelf-citationExcessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay
Karam, J. H., Grodsky, G. M., Forsham, P. H., & McWilliams, N. B. (1963) · Diabetes · doi:10.2337/diab.12.3.197 · Cited by 591
Rabinowitz, D., & Zierler, K. L. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104676 · Cited by 521
Shen, S.-W., Reaven, G. M., & Farquhar, J. W. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106433 · Cited by 494
A model of the kinetics of insulin in man
Sherwin, R. S., Kramer, K. J., Tobin, J. D., Insel, P. A., Liljenquist, J. E., Berman, M., & Andres, R. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107697 · Cited by 460
A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling
Grodsky, G. M. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107011 · Cited by 395
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Statistical Analysis: A Computer Oriented Approach.
Pektau, A. J., Afifi, A. A., & Azen, S. P. (1980) · Journal of the American Statistical Association · doi:10.2307/2287217 · Cited by 324
Toffolo, G., Bergman, R. N., Finegood, D. T., Bowden, C. R., & Cobelli, C. (1980) · Diabetes · doi:10.2337/diab.29.12.979 · Cited by 292
Self-citation
Research works printed but not linked: 2
- [18]18. Goodwin, C., and R. L. Payne. 1977. Dynamic System Identification. Academic Press, Inc., New York.
- [14]14. Bergman, R. N., C. R. Bowden, and C. Cobelli. 1981. The minimal model approach to quantification of factors controlling glucose disposal in man. In Carbohydrate Metabolism: Quantitative Physiology and Mathematical Modeling. C. Cobelli, and R. Bergman, editors. John Wiley & Sons, Inc., London. 269–296.
Cited by
Items 501–600 of 1,647
Glucagon secretion in relation to insulin sensitivity in healthy subjects
Åhrén, B. (2005) · Diabetologia · doi:10.1007/s00125-005-0056-8 · Cited by 40
Variation in IGF2BP2 Interacts With Adiposity to Alter Insulin Sensitivity in Mexican Americans
Li, X., Allayee, H., Xiang, A. H., Trigo, E., Hartiala, J., Lawrence, J. M., Buchanan, T. A., & Watanabe, R. M. (2009) · Obesity · doi:10.1038/oby.2008.593 · Cited by 40
Glucose-Insulin Control of Type1 Diabetic Patients in H2/H ∞ Space Via Computer Algebra
Kovács, L., & Paláncz, B. (2007) · Lecture notes in computer science · doi:10.1007/978-3-540-73433-8_8 · Cited by 42
A trajectory splicing approach to concretizing counterexamples for hybrid systems
Zutshi, A., Sankaranarayanan, S., Deshmukh, J. V., & Kapinski, J. P. (2013) · IEEE Conference on Decision and Control (CDC) · doi:10.1109/cdc.2013.6760488 · Cited by 36
Henderson, D. C., Fan, X., Sharma, B., Copeland, P. M., Borba, C. P., Boxill, R., Freudenreich, O., Cather, C., Evins, A. E., & Goff, D. C. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01325.x · Cited by 39
Kim, J. Y., Goran, M. I., Toledo‐Corral, C. M., Weigensberg, M. J., Choi, M., & Shaibi, G. Q. (2013) · Diabetes Care · doi:10.2337/dc12-1861 · Cited by 46
Kölle, K., Biester, T., Christiansen, S. C., Fougner, A. L., & Stavdahl, Ø. (2019) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2019.2908897 · Cited by 41
Multi-objective blood glucose control for type 1 diabetes
Dua, P., Doyle, F. J., & Pistikopoulos, E. N. (2009) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-009-0453-0 · Cited by 40
Gresl, T. A., Colman, R. J., Havighurst, T. C., Byerley, L. O., Allison, D. B., Schoeller, D. A., & Kemnitz, J. W. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00651.2002 · Cited by 39
Closed-loop insulin delivery – what lies between where we are and where we are going?
Steil, G. M., & Rebrin, K. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.353 · Cited by 39
Muscle Fiber Composition and Capillary Density in Turner Syndrome
Gravholt, C. H., Nyholm, B., Saltin, B., Schmitz, O., & Christiansen, J. S. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1668 · Cited by 39
Insulin Resistance and Preeclampsia
Berkowitz, K. M. (1998) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30088-5 · Cited by 42
Estimation of β-cell secretion and insulin hepatic extraction by the minimal modelling technique
Pacini, G., & Cobelli, C. (1990) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(90)90106-j · Cited by 41
Self-citationHaploinsufficiency of CYP8B1 associates with increased insulin sensitivity in humans
Zhong, S., Chèvre, R., Mayan, D. C., Corlianò, M., Cochran, B. J., Sem, K. P., van Dijk, T. H., Peng, J., Tan, L. J., Hartimath, S. V., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci152961 · Cited by 40
Tang, C., Naassan, A. E., Chamson-Reig, A., Koulajian, K., Goh, T. T., Yoon, F., Oprescu, A. I., Ghanim, H., Lewis, G. F., Dandona, P., et al. (2013) · Endocrinology · doi:10.1210/en.2012-1720 · Cited by 38
Lee, D. W., Lee, S. H., Choi, N., & Sung, J. H. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27151 · Cited by 42
Tayek, J. A., Manglik, S., & Abemayor, E. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90291-2 · Cited by 38
Model predictive control for infusion pump insulin delivery
Parker, R. S., Doyle, J. F., Harting, J. E., et al. (1996) · Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society · doi:10.1109/iembs.1996.646272 · Cited by 38
Mechanisms for Hyperglycemia in the Metabolic Syndrome: The Key Role of β‐Cell Dysfunction
Porte, D. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07786.x · Cited by 46
Lévy, J., Rudenski, A. S., Burnett, M. A., Knight, R., Matthews, D. R., & Turner, R. C. (1991) · Diabetologia · doi:10.1007/bf00403285 · Cited by 41
Lee, E. J., Alonso, L. C., Stefanovski, D., Strollo, H., Romano, L. C., Zou, B., Singamsetty, S., Yester, K. A., McGaffin, K. R., García-Ocaña, A., et al. (2012) · European Journal of Applied Physiology · doi:10.1007/s00421-012-2452-3 · Cited by 39
Real-Time Model-Based Fault Detection of Continuous Glucose Sensor Measurements
Turksoy, K., Roy, A., & Çınar, A. (2016) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2535412 · Cited by 38
Visentin, R., Schiavon, M., Göbel, B., Riz, M., Cobelli, C., Klabunde, T., & Dalla Man, C. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13939 · Cited by 37
Self-citationJensen, C. B., Storgaard, H., Holst, J. J., Dela, F., Madsbad, S., & Vaag, A. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021430 · Cited by 39
Estimation of plasma insulin from plasma glucose
Neatpisarnvanit, C., & Boston, J. R. (2002) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2002.804599 · Cited by 38
Taniguchi, A., Nakai, Y., Fukushima, M., Imura, H., Kawamura, H., Nagata, I., Florant, G. L., & Tokuyama, K. (1994) · Metabolism · doi:10.1016/0026-0495(94)90119-8 · Cited by 36
Shin, K. (2017) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · doi:10.15616/bsl.2017.23.4.348 · Cited by 38
Ward, W. K., Castle, J. R., & Youssef, J. E. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500608 · Cited by 36
Personalizing physical exercise in a computational model of fuel homeostasis
Palumbo, M. C., Morettini, M., Tieri, P., Diele, F., Sacchetti, M., & Castiglione, F. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006073 · Cited by 36
A Model-Based Approach to Support Validation of Medical Cyber-Physical Systems
Silva, L. C. E., de Almeida, H. O., Perkusich, Â., et al. (2015) · Sensors · doi:10.3390/s151127625 · Cited by 36
Åhrén, B., & Thorsson, O. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021547 · Cited by 36
Modeling Of Insulin Action In Vivo
Bergman, R. N., Steil, G. M., Bradley, D. C., & Watanabe, R. M. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004241 · Cited by 42
Self-citationHigh Resolution Clinical Model-Based Assessment of Insulin Sensitivity
Lotz, T. (2007) · UC Research Repository (University of Canterbury) · doi:10.26021/2196 · Cited by 39
Digital twin predicting diet response before and after long-term fasting
Silfvergren, O., Simonsson, C., Ekstedt, M., Lundberg, P., Gennemark, P., & Cedersund, G. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010469 · Cited by 42
Modeling impulsive insulin delivery in insulin pump with time delays
Song, X., Huang, M., & Li, J. (2014) · SIAM Journal on Applied Mathematics · doi:10.1137/130933137 · Cited by 35
“Based on the minimal models by Bergman, Phillips, and Cobelli [7] and Cobelli, Toffolo, and Ferrannini [11], Fabietti et al.”
MethodKautzky-Willer, A., Thomaseth, K., Clodi, M., Ludvik, B., Waldhäusl, W., Prager, R., & Pacini, G. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90224-3 · Cited by 35
Human systems immunology: Hypothesis-based modeling and unbiased data-driven approaches
Arazi, A., Pendergraft, W. F., Ribeiro, R. M., Perelson, A. S., & Hacohen, N. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2012.11.003 · Cited by 42
Experimental Design for Biological Systems
Chung, M., & Haber, E. (2012) · SIAM Journal on Control and Optimization · doi:10.1137/100791063 · Cited by 36
Abadi, D. N. M., Khooban, M. H., Alfi, A., & Siahi, M. (2013) · Arabian Journal for Science and Engineering · doi:10.1007/s13369-013-0673-3 · Cited by 37
Aging is an Inevitable Risk Factor for Insulin Resistance
Refaie, M. R., Sayed‐Ahmed, N., Bakr, A. M., Aziz, M. Y. A., Kannishi, M. H. E., & Abdel-Gawad, S. S. (2006) · Journal of Taibah University Medical Sciences · doi:10.1016/s1658-3612(06)70005-1 · Cited by 48
Eberle, C., & Ament, C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600520 · Cited by 37
Mahboob, A., Senevirathne, D. K. L., Paul, P., Nabi, F., Khan, R. H., & Châari, A. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.038 · Cited by 39
Plasma and dietary vitamin E in relation to insulin secretion and sensitivity
Costacou, T., Ma, B., King, I. B., & Mayer‐Davis, E. J. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00683.x · Cited by 38
A Survey of Insulin-Dependent Diabetes—Part II: Control Methods
Takahashi, D., Yang, X., & Hu, F. (2008) · International Journal of Telemedicine and Applications · doi:10.1155/2008/739385 · Cited by 44
Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion
Watanabe, R. M., Steil, G. M., & Bergman, R. N. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.274.1.e172 · Cited by 35
“Furthermore, integrated application of the extended combined model and the Minimal Model of glucose kinetics (2, 5, 6) to intravenous glucose tolerance test data provides clinicians the ability to obtain a near complete metabolic profile for a given subject.”
MethodSelf-citationAn Adaptive Nonlinear Basal-Bolus Calculator for Patients With Type 1 Diabetes
Boiroux, D., Aradóttir, T. B., Nørgaard, K., Poulsen, N. K., Madsen, H., & Jørgensen, J. B. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816666295 · Cited by 35
González, A. H., Rivadeneira, P. S., Ferramosca, A., Magdelaine, N., & Moog, C. H. (2020) · Optimal Control Applications and Methods · doi:10.1002/oca.2647 · Cited by 34
PWD/PhJ and WSB/EiJ Mice Are Resistant to Diet-Induced Obesity But Have Abnormal Insulin Secretion
Lee, K. T. Y., Karunakaran, S., Ho, M. M., & Clee, S. M. (2011) · Endocrinology · doi:10.1210/en.2011-0060 · Cited by 34
Stefanovski, D., Richey, J. M., Woolcott, O., Lottati, M., Zheng, D., Harrison, L. N., Ionut, V., Kim, S. P., Hsu, I., & Bergman, R. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018134 · Cited by 34
Self-citationThe Disposition Index Does Not Reflect β-Cell Function in IGT Subjects Treated With Pioglitazone
DeFronzo, R. A., Tripathy, D., Abdul-Ghani, M., Musi, N., & Gastaldelli, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1515 · Cited by 34
Giannini, C., Man, C. D., Groop, L., Cobelli, C., Zhao, H., Shaw, M. M., Duran, E. J., Pierpont, B. M., Bale, A. E., Caprio, S., et al. (2013) · Diabetes Care · doi:10.2337/dc13-1458 · Cited by 37
Self-citationIdentifiability Analysis of Three Control-Oriented Models for Use in Artificial Pancreas Systems
Garcia‐Tirado, J., Zuluaga-Bedoya, C. C., & Breton, M. D. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818788873 · Cited by 39
Overnight Control of Blood Glucose in People with Type 1 Diabetes
Boiroux, D., Duun‐Henriksen, A. K., Schmidt, S., Nørgaard, K., Madsbad, S., Skyggebjerg, O., Jensen, P. R., Poulsen, N. K., Madsen, H., & Jørgensen, J. B. (2012) · IFAC Proceedings Volumes · doi:10.3182/20120829-3-hu-2029.00106 · Cited by 35
Metabolic response to 36 hours of fasting in young men born small vs appropriate for gestational age
Jørgensen, S. W., Brøns, C., Bluck, L. J. C., Hjort, L., Færch, K., Thankamony, A., Gillberg, L., Friedrichsen, M. H., Dunger, D. B., & Vaag, A. A. (2014) · Diabetologia · doi:10.1007/s00125-014-3406-6 · Cited by 36
The Minimal Model of Glucose Regulation: A Biography
Bergman, R. N. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9019-8_1 · Cited by 41
Self-citationMayer‐Davis, E. J., Levin, S., Bergman, R. N., D'Agostino, R. B., Jr., Karter, A. J., & Saad, M. F. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.185 · Cited by 36
Self-citationGrey-box Modelling of Pharmacokinetic /Pharmacodynamic Systems
Torn�e, C. W., Jacobsen, J. L., Pedersen, O. B., Hansen, T. F., & Madsen, H. (2004) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-004-8323-8 · Cited by 36
Walters, J. M., Ward, G. M., Barton, J., Arackal, R., Boston, R. C., Best, J. D., & ALFORD, F. P. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90146-3 · Cited by 36
Hu, R., & Li, C. (2015) · Computational and Mathematical Methods in Medicine · doi:10.1155/2015/281589 · Cited by 34
ODE models for the management of diabetes: A review
Rathee, S., & Nilam (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0475-8 · Cited by 35
Basha, A. A., Vivekanandan, S., & Parthasarathy, P. (2018) · Health Information Science and Systems · doi:10.1007/s13755-018-0055-z · Cited by 33
Robust observer-based adaptive control of blood glucose in diabetic patients
Nath, A., Deb, D., & Dey, R. (2020) · International Journal of Control · doi:10.1080/00207179.2020.1750705 · Cited by 34
Alvarez, J. A., Bush, N. C., Choquette, S. S., Hunter, G. R., Darnell, B. E., Oster, R. A., & Gower, B. A. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-28 · Cited by 33
IDENTIFICATION OF LINEAR DYNAMIC MODELS FOR TYPE 1 DIABETES: A SIMULATION STUDY
Finan, D. A., Zisser, H., Jovanovič, L., Bevier, W. C., & Seborg, D. E. (2006) · IFAC Proceedings Volumes · doi:10.3182/20060402-4-br-2902.00503 · Cited by 33
Haverbeke, N., Herpe, T. V., Diehl, M., et al. (2008) · IFAC Proceedings Volumes · doi:10.3182/20080706-5-kr-1001.01531 · Cited by 33
Impulsive Zone MPC for Type I Diabetic Patients based on a long-term model
González, A. H., Rivadeneira, P. S., Ferramosca, A., Magdelaine, N., & Moog, C. H. (2017) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2017.08.2510 · Cited by 33
Paula, M. D., Ávila, L. O., & Martínez, E. (2015) · Applied Soft Computing · doi:10.1016/j.asoc.2015.06.041 · Cited by 38
Effect of Changes in Fat Distribution on the Rates of Change of Insulin Response in Children
Huang, T. T. ‐., Johnson, M. S., Gower, B. A., & Goran, M. I. (2002) · Obesity Research · doi:10.1038/oby.2002.133 · Cited by 40
Insulin resistance and the polycystic ovary syndrome
Hao, G. (2005) · Journal of reproductive medicine · Cited by 33
Taniguchi, A., Nakai, Y., Doi, K., Fukuzawa, H., Fukushima, M., Kawamura, H., Tokuyama, K., Suzuki, M., Fujitani, J., Tanaka, H., et al. (1995) · Metabolism · doi:10.1016/0026-0495(95)90136-1 · Cited by 34
Ader, M., AGAJANIAN, T., Finegood, D. T., & Bergman, R. N. (1987) · Endocrinology · doi:10.1210/endo-120-2-725 · Cited by 32
Self-citationByerly, M. S., Salayta, M. A., Swanson, R. D., Kwon, K., Peterson, J. M., Wei, Z., Aja, S. M., Moran, T. H., Blackshaw, S., & Wong, G. W. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12122 · Cited by 35
Segall‐Gutierrez, P., Xiang, A. H., Watanabe, R. M., Trigo, E., Stanczyk, F. Z., Liu, X., Jurow, R., & Buchanan, T. A. (2011) · Contraception · doi:10.1016/j.contraception.2011.04.016 · Cited by 32
Olckers, A., Towers, G. W., van der Merwe, A., Schwarz, P. E. H., Rheeder, P., & Schutte, A. E. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.004 · Cited by 32
Saha, S., & Schwarz, P. E. H. (2017) · Journal of Public Health · doi:10.1007/s10389-017-0805-4 · Cited by 40
Bock, A., François, G., & Gillet, D. (2014) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2014.12.002 · Cited by 35
Model Identification using Continuous Glucose Monitoring Data for Type 1 Diabetes
Boiroux, D., Hagdrup, M., Mahmoudi, Z., Poulsen, N. K., Madsen, H., & Jørgensen, J. B. (2016) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2016.07.279 · Cited by 31
Hansen, C. S., Færch, K., Jørgensen, M. E., Malík, M., Witte, D. R., Brunner, E. J., Tabák, Á. G., Mika Kivimaki, B., & Vistisen, D. (2019) · Diabetes Care · doi:10.2337/dc18-1838 · Cited by 36
Percival, M. W., Zisser, H., Jovanovic, L. G., & Doyle, F. J. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200415 · Cited by 32
Malin, S. K., Kashyap, S., Hammel, J. P., Miyazaki, Y., DeFronzo, R. A., & Kirwan, J. P. (2014) · Diabetes Care · doi:10.2337/dc13-3011 · Cited by 32
Modeling of glucose regulation and insulin-signaling pathways
Chew, Y. H., Shia, Y. L., Lee, C. T., Majid, F. A. A., Chua, L. S., Sarmidi, M. R., & Aziz, R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.01.018 · Cited by 37
Potentiated β-cell response to non-glucose stimuli in insulin-resistant C57BL/6J mice
Simonsson, E., & Åhrén, B. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00236-2 · Cited by 31
The long term health consequences of polycystic ovary syndrome
Kelly, C. J. G., Connell, J., Cameron, I. T., Gould, G. W., & Lyall, H. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11644.x · Cited by 34
Dubé, M. P., Edmondson‐Melançon, H., Qian, D., Aqeel, R., Johnson, D. L., & Buchanan, T. A. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200106010-00006 · Cited by 30
What Is Gestational Diabetes—Really?
Buchanan, T. A., Xiang, A. H., Page, K. A., & Watanabe, R. M. (2025) · Diabetes · doi:10.2337/dbi24-0041 · Cited by 31
Hermans, M. P., Pepersack, T., Godeaux, L. H., Beyer, I., & Turc, A. (2005) · The Journals of Gerontology Series A · doi:10.1093/gerona/60.2.241 · Cited by 32
Robust servo control of a novel type 1 diabetic model
Kovács, L., Kulcsár, B., György, A., & Benyó, Z. (2010) · Optimal Control Applications and Methods · doi:10.1002/oca.963 · Cited by 31
Krueger, E. S., Beales, J. L., Russon, K. B., Elison, W. S., Davis, J., Hansen, J. M., Neilson, A. P., Hansen, J. M., & Tessem, J. S. (2021) · Biomolecules · doi:10.3390/biom11121892 · Cited by 33
On the existence and uniqueness analysis of fractional blood glucose-insulin minimal model
Dubey, R. S., Goswami, P., Başkonuş, H. M., & Gomati, A. T. (2022) · Advances in Complex Systems · doi:10.1142/s1793962323500083 · Cited by 31
Budiman, E. S., Samant, N., & Resch, A. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700213 · Cited by 30
Clinical Measures of Islet Function: Usefulness to Characterize Defects in Diabetes
Åhrén, B., Pratley, R. E., Soubt, M., Dunning, B. E., & Foley, J. E. (2008) · Current Diabetes Reviews · doi:10.2174/157339908784220714 · Cited by 32
Beta cell function in type 1 diabetes determined from clinical and fasting biochemical variables
the Type 1 Diabetes TrialNet Study Group, Wentworth, J. M., the Immune Tolerance Network Study Group, Bediaga, N. G., Giles, L. C., Ehlers, M. R., Gitelman, S. E., Geyer, S. M., Evans‐Molina, C., & Harrison, L. C. (2018) · Diabetologia · doi:10.1007/s00125-018-4722-z · Cited by 31
Ho, R. C., Davy, K. P., Davy, B. M., & Melby, C. L. (2002) · Metabolism · doi:10.1053/meta.2002.35577 · Cited by 213
Early disturbances in insulin secretion in the development of type 2 diabetes mellitus
van Haeften, T. W. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00267-8 · Cited by 41
Mathematical models of insulin secretion in physiological and clinical investigations
Pacini, G. (1994) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(94)90059-0 · Cited by 30
Fisher, G., Hunter, G. R., & Gower, B. A. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00843.2011 · Cited by 29
Buse, J. B., Polonsky, K. S., & Burant, C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00031-6 · Cited by 51
Tripathy, D., Cobb, J. E., Gall, W., Adam, K., George, T., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3824 · Cited by 30
Inherited destiny? Genetics and gestational diabetes mellitus
Watanabe, R. M. (2011) · Genome Medicine · doi:10.1186/gm232 · Cited by 36
Parker, R. S., & Clermont, G. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0517 · Cited by 33
Metadata
- Authors
- Bergman, R. N., Phillips, L. S., & Cobelli, C.
- Affiliations
- Northwestern University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1981-12-01
- Volume
- 68
- Issue
- 6
- Pages
- 1456-1467
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC370948
- OpenAlex
- W2156353972
- Cited by
- 1,640
- References
- 30
- Citations by year
- 2026: 32 · 2025: 38 · 2024: 44 · 2023: 31 · 2022: 45 · 2021: 59 · 2020: 50 · 2019: 55 · 2018: 66 · 2017: 66 · 2016: 59 · 2015: 63 · 2014: 60 · 2013: 59 · 2012: 73
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Northwestern University
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK029867)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glucose tolerance, insulin sensitivity, beta-cell glucose sensitivity, insulin resistance, pancreatic insufficiency, intravenous glucose tolerance test, first-phase insulin response, second-phase insulin response, obesity, impaired glucose tolerance, insulin kinetics, glucose kinetics
- MeSH terms
- Body Weight, Female, Glucose, Glucose Tolerance Test, Humans, Infusions, Parenteral, Insulin, Kinetics, Male, Models, Biological, Obesity, Pancreas
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.